Literature DB >> 26483346

miR-342-3p regulates MYC transcriptional activity via direct repression of E2F1 in human lung cancer.

Mei Chee Tai, Taisuke Kajino, Masahiro Nakatochi1, Chinatsu Arima, Yukako Shimada, Motoshi Suzuki, Hiroyuki Miyoshi2, Yasushi Yatabe3, Kiyoshi Yanagisawa, Takashi Takahashi.   

Abstract

Accumulating evidence indicates that altered miRNA expression is crucially involved in lung cancer development, though scant information is available regarding how MYC, an archetypical oncogene, is regulated by miRNAs, especially via a mechanism involving MYC cofactors. In this study, we attempted to identify miRNAs involved in regulation of MYC transcriptional activity in lung cancer. To this end, we utilized an integrative approach with combinatorial usage of miRNA and mRNA expression profile datasets of patient tumor tissues, as well as those of MYC-inducible cell lines in vitro. In addition to miRNAs previously reported to be directly regulated by MYC, including let-7 and miR-17-92, our strategy also helped to identify miR-342-3p as capable of indirectly regulating MYC activity via direct repression of E2F1, a MYC-cooperating molecule. Furthermore, miR-342-3p module activity, which we defined as a gene set reflecting the experimentally substantiated influence of miR-342-3p on mRNA expression, was found to be inversely correlated with MYC activity reflected by MYC module activity in three independent datasets of lung adenocarcinoma patients obtained from the Director's Challenge Consortium of the United States (P = 1.94 × 10(-73)), the National Cancer Center of Japan (P = 9.05 × 10(-34)) and the present study (P = 1.17 × 10(-19)). Our integrative approach appears to be useful to elucidate inter-regulatory relationships between miRNAs and protein coding genes of interest, even those present in patient tumor tissues, which remains a challenge to better understand the pathogenesis of this devastating disease.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26483346     DOI: 10.1093/carcin/bgv152

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  32 in total

1.  Divergent lncRNA MYMLR regulates MYC by eliciting DNA looping and promoter-enhancer interaction.

Authors:  Taisuke Kajino; Teppei Shimamura; Shuyi Gong; Kiyoshi Yanagisawa; Lisa Ida; Masahiro Nakatochi; Sebastian Griesing; Yukako Shimada; Keiko Kano; Motoshi Suzuki; Satoru Miyano; Takashi Takahashi
Journal:  EMBO J       Date:  2019-07-30       Impact factor: 11.598

2.  Upregulation of microRNA-18b induces phosphatase and tensin homolog to accelerate the migration and invasion abilities of ovarian cancer.

Authors:  Xiaofang Han; Yan Zhang; Dong Wang; Xinyun Fu; Meiqing Li; Aiming Wang
Journal:  Oncol Lett       Date:  2017-08-31       Impact factor: 2.967

3.  Coordination of Myeloid Differentiation with Reduced Cell Cycle Progression by PU.1 Induction of MicroRNAs Targeting Cell Cycle Regulators and Lipid Anabolism.

Authors:  Lauren A Solomon; Shreya Podder; Jessica He; Nicholas L Jackson-Chornenki; Kristen Gibson; Rachel G Ziliotto; Jess Rhee; Rodney P DeKoter
Journal:  Mol Cell Biol       Date:  2017-05-02       Impact factor: 4.272

4.  Long noncoding RNA FTX is upregulated in gliomas and promotes proliferation and invasion of glioma cells by negatively regulating miR-342-3p.

Authors:  Weiguang Zhang; Yunke Bi; Jianhua Li; Fei Peng; Hui Li; Chenguang Li; Laizang Wang; Fubin Ren; Chen Xie; Pengwei Wang; Weiwei Liang; Zhi Wang; Dan Zhu
Journal:  Lab Invest       Date:  2017-01-23       Impact factor: 5.662

5.  Expression and prognostic value of E2F activators in NSCLC and subtypes: a research based on bioinformatics analysis.

Authors:  Zhaojia Gao; Run Shi; Kai Yuan; Yong Wang
Journal:  Tumour Biol       Date:  2016-09-21

6.  Predictive relevance of miR-34a, miR-224 and miR-342 in patients with advanced squamous cell carcinoma of the lung undergoing palliative chemotherapy.

Authors:  Vlastimil Kulda; Martin Svaton; Petr Mukensnabl; Kristyna Hrda; Pavel Dvorak; Zbynek Houdek; Katerina Houfkova; Radana Vrzakova; Vaclav Babuska; Milos Pesek; Martin Pesta
Journal:  Oncol Lett       Date:  2017-11-02       Impact factor: 2.967

7.  Long non-coding RNA H19 regulates FOXM1 expression by competitively binding endogenous miR-342-3p in gallbladder cancer.

Authors:  Shou-Hua Wang; Fei Ma; Zhao-Hui Tang; Xiao-Cai Wu; Qiang Cai; Ming-Di Zhang; Ming-Zhe Weng; Di Zhou; Jian-Dong Wang; Zhi-Wei Quan
Journal:  J Exp Clin Cancer Res       Date:  2016-10-03

8.  Increased S100A15 expression and decreased DNA methylation of its gene promoter are involved in high metastasis potential and poor outcome of lung adenocarcinoma.

Authors:  Yung-Che Chen; Meng-Chih Lin; Chang-Chun Hsiao; Yi-Xin Zheng; Kuang-Den Chen; Ming-Tse Sung; Chung-Jen Chen; Ting-Ya Wang; Yong-Yong Lin; Huang-Chih Chang; Yu-Mu Chen; Jen-Chieh Chang
Journal:  Oncotarget       Date:  2017-07-11

9.  Predictive microRNAs for lymph node metastasis in endoscopically resectable submucosal colorectal cancer.

Authors:  Chan Kwon Jung; Seung-Hyun Jung; Seon-Hee Yim; Ji-Han Jung; Hyun Joo Choi; Won-Kyung Kang; Sung-Won Park; Seong-Taek Oh; Jun-Gi Kim; Sug Hyung Lee; Yeun-Jun Chung
Journal:  Oncotarget       Date:  2016-05-31

10.  Atherosclerosis is exacerbated by chitinase-3-like-1 in amyloid precursor protein transgenic mice.

Authors:  Yu Yeon Jung; Ki Cheon Kim; Mi Hee Park; Youngsik Seo; Heonyong Park; Min Hee Park; Jun Chang; Dae Youn Hwang; Sang Bae Han; Sanghyeon Kim; Dong Ju Son; Jin Tae Hong
Journal:  Theranostics       Date:  2018-01-01       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.